Synthetic Marijuana (K2) Induced Acute Liver Failure
Marco A. Paez, Adebayo Christian Atanda, Yewande E. Odeyemi, Alem Mehari, Wayne Davis, Adeyinka O. Laiyemo
Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC, USA
Med Sci Case Rep 2017; 4:83-86
Available online: 2017-08-18
The use of synthetic marijuana has recently emerged as a public health problem. Sold as “herbal incense”, synthetic marijuana belongs to the family of designer drugs that have psychoactive properties similar to cannabis but due to their altered biochemical nature, their psychological and physiological effects are more potent.
CASE REPORT: We present a case of a 56-year-old male with a history of synthetic marijuana use that developed acute liver failure. Other causes of liver failure were ruled out. The patient was empirically treated with N-acetylcysteine and made a full recovery.
CONCLUSIONS: With the use of synthetic marijuana on the rise, physicians need to maintain a high clinical suspicion when encountering a patient who develops acute liver failure.
Keywords: Acetylcysteine, Cannabinoid Receptor Agonists, drug-induced liver injury, Liver Failure, Acute